These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 19879857

  • 1. Reverse phase protein array identifies novel anti-invasion mechanisms of YC-1.
    Hong B, Lui VW, Hui EP, Lu Y, Leung HS, Wong EY, Cheng SH, Ng MH, Mills GB, Chan AT.
    Biochem Pharmacol; 2010 Mar 15; 79(6):842-52. PubMed ID: 19879857
    [Abstract] [Full Text] [Related]

  • 2. Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activation.
    Hong B, Lui VW, Hui EP, Ng MH, Cheng SH, Sung FL, Tsang CM, Tsao SW, Chan AT.
    Invest New Drugs; 2011 Jun 15; 29(3):401-10. PubMed ID: 20013349
    [Abstract] [Full Text] [Related]

  • 3. Anti-invasion, anti-proliferation and anoikis-sensitization activities of lapatinib in nasopharyngeal carcinoma cells.
    Lui VW, Lau CP, Ho K, Ng MH, Cheng SH, Tsao SW, Tsang CM, Lei KI, Chan AT, Mok TS.
    Invest New Drugs; 2011 Dec 15; 29(6):1241-52. PubMed ID: 20571878
    [Abstract] [Full Text] [Related]

  • 4. YC-1 induces S cell cycle arrest and apoptosis by activating checkpoint kinases.
    Yeo EJ, Ryu JH, Chun YS, Cho YS, Jang IJ, Cho H, Kim J, Kim MS, Park JW.
    Cancer Res; 2006 Jun 15; 66(12):6345-52. PubMed ID: 16778212
    [Abstract] [Full Text] [Related]

  • 5. Cisplatin suppresses proliferation, migration and invasion of nasopharyngeal carcinoma cells in vitro by repressing the Wnt/β-catenin/Endothelin-1 axis via activating B cell translocation gene 1.
    Yin P, Song G, Jiang Z.
    Cancer Chemother Pharmacol; 2018 May 15; 81(5):863-872. PubMed ID: 29536130
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma.
    Lau CK, Yang ZF, Lam SP, Lam CT, Ngai P, Tam KH, Poon RT, Fan ST.
    Cancer Biol Ther; 2007 Dec 15; 6(12):1900-7. PubMed ID: 18059167
    [Abstract] [Full Text] [Related]

  • 7. Tolfenamic Acid Inhibits the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma: Involvement of p38-Mediated Down-Regulation of Slug.
    Jittreetat T, Shin YS, Hwang HS, Lee BS, Kim YS, Sannikorn P, Kim CH.
    Yonsei Med J; 2016 May 15; 57(3):588-98. PubMed ID: 26996556
    [Abstract] [Full Text] [Related]

  • 8. Met tyrosine kinase inhibitor, PF-2341066, suppresses growth and invasion of nasopharyngeal carcinoma.
    Zhao Y, Zhang J, Tian Y, Xue C, Hu Z, Zhang L.
    Drug Des Devel Ther; 2015 May 15; 9():4897-907. PubMed ID: 26345996
    [Abstract] [Full Text] [Related]

  • 9. Caffeic Acid Phenethyl Ester Induces N-myc Downstream Regulated Gene 1 to Inhibit Cell Proliferation and Invasion of Human Nasopharyngeal Cancer Cells.
    Chiang KC, Yang SW, Chang KP, Feng TH, Chang KS, Tsui KH, Shin YS, Chen CC, Chao M, Juang HH.
    Int J Mol Sci; 2018 May 08; 19(5):. PubMed ID: 29738439
    [Abstract] [Full Text] [Related]

  • 10. miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and invasion.
    Xia H, Ng SS, Jiang S, Cheung WK, Sze J, Bian XW, Kung HF, Lin MC.
    Biochem Biophys Res Commun; 2010 Jan 01; 391(1):535-41. PubMed ID: 19931509
    [Abstract] [Full Text] [Related]

  • 11. YC-1 [3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl Indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G0-G1 in human hepatocellular carcinoma cells.
    Wang SW, Pan SL, Guh JH, Chen HL, Huang DM, Chang YL, Kuo SC, Lee FY, Teng CM.
    J Pharmacol Exp Ther; 2005 Mar 01; 312(3):917-25. PubMed ID: 15525795
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The new 6q27 tumor suppressor DACT2, frequently silenced by CpG methylation, sensitizes nasopharyngeal cancer cells to paclitaxel and 5-FU toxicity via β-catenin/Cdc25c signaling and G2/M arrest.
    Zhang Y, Fan J, Fan Y, Li L, He X, Xiang Q, Mu J, Zhou D, Sun X, Yang Y, Ren G, Tao Q, Xiang T.
    Clin Epigenetics; 2018 Feb 27; 10(1):26. PubMed ID: 30359298
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells.
    Kang JI, Hong JY, Lee HJ, Bae SY, Jung C, Park HJ, Lee SK.
    PLoS One; 2015 Feb 27; 10(12):e0144368. PubMed ID: 26656173
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
    Liu Y, Liu Q, Chen S, Liu Y, Huang Y, Chen P, Li X, Gao G, Xu K, Fan S, Zeng Z, Xiong W, Tan M, Li G, Zhang W.
    FASEB J; 2019 Nov 27; 33(11):11959-11972. PubMed ID: 31408612
    [Abstract] [Full Text] [Related]

  • 18. Folic acid inhibits nasopharyngeal cancer cell proliferation and invasion via activation of FRα/ERK1/2/TSLC1 pathway.
    Liu Z, Jin X, Pi W, Liu S.
    Biosci Rep; 2017 Dec 22; 37(6):. PubMed ID: 29070520
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.